Baxter (BAX) sees early weakness
Tweet Send to a Friend
Baxter (NYSE: BAX) sees early weakness which could be related to an FDA warning letter related to an inspection of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




